Tsondai Priscilla Ruvimbo, Wilkinson Lynne Susan, Grimsrud Anna, Mdlalo Precious Thembekile, Ullauri Angelica, Boulle Andrew
School of Public Health and Family Medicine, University Of Cape Town, Cape Town, South Africa.
Médecins Sans Frontières, Cape Town, South Africa.
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21649. doi: 10.7448/IAS.20.5.21649.
Increasingly, there is a need for health authority scale up of successfully piloted differentiated models of antiretroviral therapy (ART) delivery. However, there is a paucity of evidence on system-wide outcomes after scale-up. In the Cape Town health district, stable adult patients were referred to adherence clubs (ACs) - a group model of ART delivery with five visits per year. By the end of March 2015, over 32,000 ART patients were in an AC. We describe patient outcomes of a representative sample of AC patients during this scale-up.
Patients enrolled in an AC at non-research supported sites between 2011 and 2014 were eligible for analysis. We sampled 10% of ACs ( = 100) in quintets proportional to the number of ACs at each facility, linking each patient to city-wide laboratory and service access data to validate retention and virologic outcomes. We digitized registers and used competing risks regression and cross-sectional methods to estimate outcomes: mortality, transfers, loss to follow-up (LTFU) and viral load suppression (≤400 copies/mL). Predictors of LTFU and viral rebound were assessed using Cox proportional hazards models.
Of the 3216 adults contributing 4019 person years of follow-up (89% in an AC, median 1.1 years), 70% were women. Retention was 95.2% (95% CI, 94.0-96.4) at 12 months and 89.3% (95% CI, 87.1-91.4) at 24 months after AC enrolment. In the 13 months prior to analysis closure, 88.1% of patients had viral load assessments and of those, viral loads ≤400 copies/mL were found in 97.2% (95% CI, 96.5-97.8) of patients. Risk of LTFU was higher in younger patients and in patients accessing ART from facilities with larger ART cohorts. Risk of viral rebound was higher in younger patients, those that had been on ART for longer and patients that had never sent a buddy to collect their medication.
This is the first analysis reporting patient outcomes after health authorities scaled-up a differentiated care model across a high burden district. The findings provide substantial reassurance that stable patients on long-term ART can safely be offered care options, which are more convenient to patients and less burdensome to services.
卫生当局越来越需要扩大成功试点的差异化抗逆转录病毒疗法(ART)提供模式。然而,关于扩大规模后全系统结果的证据却很少。在开普敦卫生区,病情稳定的成年患者被转介到依从性俱乐部(ACs)——一种每年进行五次访视的ART提供小组模式。到2015年3月底,超过32000名接受ART治疗的患者加入了ACs。我们描述了在这一扩大规模过程中AC患者代表性样本的患者结果。
2011年至2014年期间在非研究支持地点加入AC的患者符合分析条件。我们按比例抽取了10%的AC(n = 100),抽取数量与每个机构的AC数量成五分之一比例关系,将每位患者与全市范围的实验室和服务获取数据相链接,以验证留存率和病毒学结果。我们将登记册数字化,并使用竞争风险回归和横断面方法来估计结果:死亡率、转诊、失访(LTFU)和病毒载量抑制(≤400拷贝/毫升)。使用Cox比例风险模型评估LTFU和病毒反弹的预测因素。
在3216名成年人中,有4019人年的随访期(89%在AC中,中位数为1.1年),其中70%为女性。加入AC后12个月的留存率为95.2%(95%CI,94.0 - 96.4),24个月时为89.3%(95%CI,87.1 - 91.4)。在分析结束前的13个月里,88.1%的患者进行了病毒载量评估,其中97.2%(95%CI,96.5 - 97.8)的患者病毒载量≤400拷贝/毫升。年轻患者以及从ART队列较大的机构获取ART治疗的患者LTFU风险更高。年轻患者、接受ART治疗时间较长的患者以及从未派同伴取药的患者病毒反弹风险更高。
这是首次分析报告卫生当局在高负担地区扩大差异化护理模式后患者的结果。这些发现提供了充分的保证,即长期接受ART治疗的稳定患者可以安全地获得对患者更方便且对服务负担更小的护理选择。